Navigation Links
Detroit Medical Center Becomes First in Southeast Michigan to Study an Implantable Device, Designed to Reduce Patient Time to the ER and Improve Survival Rates From Heart Attack in High-Risk Patients
Date:3/28/2011

DETROIT, March 28, 2011 /PRNewswire-USNewswire/ -- Detroit Medical Center (DMC) Cardiovascular Institute (CVI) announced its first implant of the AngelMed Guardian cardiac monitor and alert system. The system is designed to reduce the time it takes patients to get to the emergency room during an impending heart attack.  Randy Lieberman, M.D., Medical Director, Electrophysiology Services, DMC CVI, performed the first implant in Southeast Michigan, and is among the very first physicians across the United States to implant the experimental device.

The AngelMed Guardian system is designed to track significant changes in the heart's electrical signal and then alert patients to seek medical attention.  The objective of the ALERTS Pivotal Study is to provide an assessment of the safety and effectiveness of the AngelMed Guardian System.

"This study provides an excellent opportunity for some of our patients who are at high-risk of having another heart attack. The device is designed to measure changes in the electrical signal of the heart and alert the patient at the earliest onset of a heart attack so that they can get treatment as soon as possible," said Dr. Lieberman.

According to the American Heart Association, one of every five deaths in the United States is attributable to coronary heart disease. Further, 50 percent of heart-attack fatalities occur within one hour of symptom onset and occur before the patient even reaches the hospital.

The AngelMed Guardian System is comprised of an internal implantable device about the size of a standard pacemaker with a lead into the heart, an external telemetry device, and a programmer that aids physicians in evaluating heart signals.

DMC Cardiovascular Institute is among the first medical facilities to participate in the AngelMed Guardian system trial. To participate in the ALERTS study, patients must meet various inclusion criteria. For more information on the AngelMed Guardian system or the ALERTS study protocol, contact (313) 745-7025.

DMC Cardiovascular Institute is also home to DMC Cardio Team One: The most innovative cardiac response program in the nation. Cardio Team One physicians are on-site, not on call, 24/7, allowing DMC to cut heart attack response time to half the national average and well under the national standard.

The pioneering "DMC Cardio Team One" approach to heart attacks has already begun saving the lives of patients who previously might have died by treating them in half the time of the national standard average which is 90–120 minutes.

Theodore L. Schreiber, M.D., President, DMC Cardiovascular Institute, said "it's very gratifying to be able to offer another innovative procedure to our heart patients. We are committed to providing the very best, world-class care here at the Detroit Medical Center."

This new procedure comes immediately on the heels of DMC Cardiovascular Institute's completion of the first two Medtronic CoreValve® transcatheter aortic valve implants (TAVI) ever achieved in Michigan, earlier this month. That procedure was part of CVI's participation in the Medtronic CoreValve U.S. Clinical Trial. This multi-state trial will evaluate a new, non-surgical alternative to open-heart surgery for patients with severe aortic stenosis.

Physicians are available for interviews.

For more information on this clinical trial and others, visit www.DMCCVI.org.

About Detroit Medical Center www.dmc.org

The Detroit Medical Center operates nine hospitals and institutes, including Children's Hospital of Michigan, Detroit Receiving Hospital, Harper University Hospital, Huron Valley-Sinai Hospital, Hutzel Women's Hospital, Rehabilitation Institute of Michigan, Sinai-Grace Hospital, DMC Surgery Hospital, and DMC Cardiovascular Institute. The Detroit Medical Center is a leading regional healthcare system with a mission of excellence in clinical care, research and medical education.


'/>"/>
SOURCE Detroit Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat
2. Detroit Medical Center Chooses CareTech Solutions Document Imaging System
3. International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
4. Researchers at the Karmanos Cancer Institute in Detroit Discover Feasibility of Chemotherapy Alternative
5. Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
6. Olympic Gold Medalist Kristi Yamaguchi Joins American Lung Association of Michigan to Address Seriously Low Vaccination Rates; Urge Metro-Detroiters to Get Immunized This Season
7. Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
8. St. Davids HealthCare Takes Robotic-Assisted Surgery to the Next Level With the Texas Institute for Robotic Surgery at St. Davids North Austin Medical Center
9. "The State of the Medical Marijuana Markets 2011" First Ever Investor-Grade Analysis Report of the Marijuana Marketplace in the United States
10. Plans to Overhaul Ambulance Industry Met With Enthusiasm: Online Marketplace for Emergency Medical Services Introduces Largest Selection of Products and Services on the Web
11. Gateway to Hope: Missouri Nonprofit Leads the Fight against Breast Cancer by Providing Donated Medical and Surgical Care at No Cost to Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017 AVACEN Medical , Inc. (AVACEN) ... their  2017 New Product Innovation Award for Its fibromyalgia ... and secondary medical device market research by Frost & Sullivan,s ... OTC, drug-free pain relief product, the AVACEN 100, offers a ... fibromyalgia widespread pain. ...
(Date:10/11/2017)... 2017  Caris Life Sciences ® , a leading ... of precision medicine, today announced that St. Jude Medical ... Alliance™ (POA) as its 17 th member. Through ... Crosson Cancer Institute will help develop standards of care ... profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
Breaking Medicine News(10 mins):